Literature DB >> 12395149

Linear closed mini DNA generated by the prokaryotic cleaving-joining enzyme TelN is functional in mammalian cells.

Jochen Heinrich1, Jan Schultz, Magnus Bosse, Günter Ziegelin, Erich Lanka, Karin Moelling.   

Abstract

For application of DNA in gene medicine plasmid or viral DNA is usually used as a vector for the gene of interest. To generate DNA with a minimum of foreign DNA sequences, we used the prokaryotic telomerase, protelomerase TelN, of bacteriophage N15. This is a novel enzyme with cleaving-joining activity, which is required for the formation of linear prophage DNA with closed ends in lysogenic bacteria. Acting on a telomere resolution site telRL, the protelomerase converts circular plasmid DNA into linear covalently closed dumbbell-shaped molecules ("doggybones") in a single-step enzyme reaction. Two such sites were inserted into an expression plasmid flanking a gene of interest. This is cleaved and joined by means of the protelomerase, yielding linear closed mini DNA coding for green fluorescent protein (EGFP) or interleukin-12 (IL-12). Upon transient transfection of human embryonal kidney cells, EGFP was expressed at higher levels from linear closed molecules than from linear open molecules generated by restriction endonucleases for comparison. The level of transcription was comparable to that observed for the parental plasmid DNA. To test whether the linear closed mini DNA molecules are functional in vivo the B16F10/C57BL/6 melanoma metastasis model was applied, where injection of IL-12-expressing DNA inhibits metastasis formation in the lung. The anti-metastatic effect of the IL-12-expressing linear closed DNA was equal or higher than that of the parental plasmid DNA. Therefore, the TelN/ telRL system is well suited to generate linear closed mini DNA with high stability and a minimum of foreign nucleotide sequences.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12395149     DOI: 10.1007/s00109-002-0362-2

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  6 in total

Review 1.  Nonviral DNA vectors for immunization and therapy: design and methods for their obtention.

Authors:  Ernesto G Rodríguez
Journal:  J Mol Med (Berl)       Date:  2004-06-03       Impact factor: 4.599

2.  Novel synthetic plasmid and Doggybone DNA vaccines induce neutralizing antibodies and provide protection from lethal influenza challenge in mice.

Authors:  Veronica L Scott; Ami Patel; Daniel O Villarreal; Scott E Hensley; Edwin Ragwan; Jian Yan; Niranjan Y Sardesai; Paul J Rothwell; Jonathan P Extance; Lisa J Caproni; David B Weiner
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Construction and characterization of an in-vivo linear covalently closed DNA vector production system.

Authors:  Nafiseh Nafissi; Roderick Slavcev
Journal:  Microb Cell Fact       Date:  2012-12-06       Impact factor: 5.328

4.  Physical Characterization of Gemini Surfactant-Based Synthetic Vectors for the Delivery of Linear Covalently Closed (LCC) DNA Ministrings.

Authors:  Chi Hong Sum; Nafiseh Nafissi; Roderick A Slavcev; Shawn Wettig
Journal:  PLoS One       Date:  2015-11-12       Impact factor: 3.240

5.  Comparative analysis of enzymatically produced novel linear DNA constructs with plasmids for use as DNA vaccines.

Authors:  A A Walters; E Kinnear; R J Shattock; J U McDonald; L J Caproni; N Porter; J S Tregoning
Journal:  Gene Ther       Date:  2014-05-15       Impact factor: 5.250

6.  Production of lentiviral vectors using novel, enzymatically produced, linear DNA.

Authors:  Rajvinder Karda; John R Counsell; Kinga Karbowniczek; Lisa J Caproni; John P Tite; Simon N Waddington
Journal:  Gene Ther       Date:  2019-01-14       Impact factor: 5.250

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.